Related Experiment Video
Updated: Jun 27, 2025

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Association between CBL gene polymorphism and susceptibility of microscopic polyangiitis in a Chinese population: A
Liu Liu1, Yan Zhu2, Jingjing Lan3
1The Second Affiliated Hospital of Guangxi Medical University, Department of Nephrology, Nanning Guangxi, 530007, China; The First Affiliated Hospital, Department of Nephrology, Hengyang Medical School, University of South China, Hengyang Hunan, 421001, China.
Objective:
To assess whether Casitas B-lineage lymphoma (CBL) gene polymorphism influences the risk of microscopic polyangiitis (MPA) in Chinese populations.
Methods:
In total, 266 MPA patients and 297 healthy controls were recruited for a case-control study. Five CBL SNPs were genotyped using multiplex polymerase chain reaction and high-throughput sequencing. The relationship between SNPs and the risk of MPA under different genetic models was evaluated by SNPstats. SNP-SNP interaction was analyzed by generalized multifactor dimensionality reduction (GMDR). Finally, the association between CBL SNPs and treatment effects were assessed.
Results:
The results showed that CBL rs2276083 was associated with decreasing MPA risk under dominant (OR: 0.53; p = 0.014) and recessive models (OR: 0.52; p = 0.0034). Stratification analysis indicated that rs2276083 and rs2509671 in age < 60 years, rs2276083 in female or in Han population were protective factors for MPA. The CBL haplotype (A-A-G-C-T) was associated with an increased risk of MPA. GMDR suggested that CBL rs2276083, phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PI3KCA) rs1607237, and autophagy-related gene 7 (ATG7) rs7549008 might interact with each other in MPA development (p = 0.0107). CBL rs1047417 with AG genotype and rs11217234 with AG genotype had better clinical treatment effects than other two genotypes (p = 0.048 and p = 0.025, respectively).
Conclusion:
The genetic polymorphism of CBL had a potential association with the risk of MPA and clinical treatment effects in Guangxi population in China.
Insights
Genetic variations in the Casitas B-lineage lymphoma (CBL) gene may influence microscopic polyangiitis (MPA) risk and treatment outcomes in Chinese populations. Specific CBL single nucleotide polymorphisms (SNPs) showed protective effects against MPA and correlated with better clinical responses.
Area of Science:
- Genetics
- Immunology
- Clinical Medicine
Background:
- Microscopic polyangiitis (MPA) is a significant autoimmune vasculitis.
- Understanding the genetic factors contributing to MPA pathogenesis is crucial for risk stratification and targeted therapies.
Purpose of the Study:
- To investigate the association between Casitas B-lineage lymphoma (CBL) gene polymorphisms and the risk of developing microscopic polyangiitis (MPA) in a Chinese population.
- To explore the correlation between CBL gene variations and the clinical treatment effects in MPA patients.
Main Methods:
- A case-control study involving 266 MPA patients and 297 healthy controls.
- Genotyping of five CBL single nucleotide polymorphisms (SNPs) using multiplex polymerase chain reaction and high-throughput sequencing.
- Statistical analysis including SNPstats for genetic models and generalized multifactor dimensionality reduction (GMDR) for gene-gene interactions.
Main Results:
- The CBL rs2276083 SNP was significantly associated with a reduced risk of MPA under dominant and recessive models.
- Stratification analyses revealed protective effects of rs2276083 and rs2509671 in younger individuals, and rs2276083 in females and the Han population.
- Potential interactions were identified between CBL, PI3KCA, and ATG7 SNPs in MPA development. Specific CBL genotypes (rs1047417 AG and rs11217234 AG) were linked to improved treatment responses.
Conclusions:
- Casitas B-lineage lymphoma (CBL) gene polymorphism is potentially associated with both the risk of microscopic polyangiitis (MPA) and its clinical treatment effects in the Guangxi population of China.
- These findings suggest that CBL genetic variations could serve as biomarkers for MPA susceptibility and treatment efficacy.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
07:00A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...